Company Filing History:
Years Active: 2018
Title: Rakesh Rana: Innovator in Oligosaccharide-Protein Conjugation
Introduction
Rakesh Rana is a notable inventor based in New Delhi, India. He has made significant contributions to the field of synthetic oligosaccharide-protein conjugates. His innovative work focuses on improving processes that enhance the immunogenicity of vaccines.
Latest Patents
Rakesh Rana holds a patent for the "Process of conjugation and novel synthetic oligosaccharide-protein conjugates obtained thereof." This invention relates to an improved process of conjugation that results in synthetic oligosaccharide-protein (OS-PR) conjugates. The process is rapid and yields highly immunogenic conjugates that elicit specific and homogenous immune responses. The synthetic oligosaccharide consists of four to eight repeating units of respective monomers and includes at least one in-built terminal amino linker. This synthetic polysaccharide mimics natural polysaccharides derived from gram-negative bacteria. The conjugation chemistry employed is thio-ether linkage, and the entire process takes approximately 14-22 hours. These oligosaccharide-protein conjugates are valuable for producing monovalent or multivalent combination vaccines and serve as diagnostic tools.
Career Highlights
Rakesh Rana is currently associated with Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. His work at this organization emphasizes the development of innovative solutions in vaccine technology.
Collaborations
Rakesh has collaborated with notable colleagues such as Davinder Gill and Manoj Kumar Chhikara. Their combined expertise contributes to the advancement of research in the field of immunology.
Conclusion
Rakesh Rana's contributions to the field of oligosaccharide-protein conjugation represent a significant advancement in vaccine development. His innovative processes have the potential to enhance immunogenic responses and improve public health outcomes.